What Wilson's Disease and Its Treatment have Taught us About the Metabolism of Copper: Observations in 27 Cases (Q42543784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

What Wilson's Disease and Its Treatment have Taught us About the Metabolism of Copper: Observations in 27 Cases (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32886-3

25 June 2023

author name string

N. P. Goldstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5742073

25 June 2023

W. N. Tauxe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5742073

25 June 2023

J. T. McCall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5742073

25 June 2023

R. V. Randall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5742073

25 June 2023

J. B. Gross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5742073

25 June 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5742073

25 June 2023

publication date

1 July 1968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

25 October 2019

https://api.elsevier.com/content/article/PII:S0025712516328863?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32886-3

https://api.elsevier.com/content/article/PII:S0025712516328863?httpAccept=text/plain

25 June 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32886-3

Medical Clinics of North America

25 June 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

989-1001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

Genetic and biochemical aspects of Wilson's disease

25 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

The urinary excretion of copper and its concentration in the blood of normal human adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Studies on copper metabolism. XIII. Hepatolenticular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Clinical and pathological findings in a case of hepatolenticular degeneration treated with penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Hepatolenticular degeneration associated with acanthosis nigricans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Liver dysfunction in hepatolenticular degeneration; a review of eleven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

7 January 2021

Copper metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Hepatolenticular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

METAL CHELATES OF SOME SULFUR-CONTAINING AMINO ACIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Effect of D, L‐penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson's disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Increased brain radiocopper uptake in Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

The long term management of hepatolenticular degeneration (Wilson's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Environmental treatment of a hereditary illness: Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Radiocopper studies in patients with Wilson's disease and their relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Wilson's disease, portal hypertension and intrahepatic vascular obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Penicillamine, a new oral therapy for Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Current views on the pathogenesis and treatment of Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

The physiology of copper in man and its relation to Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932886-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Copper metabolism in Wilson's disease, Laennec's cirrhosis and hemachromatosis: studies with radiocopper (Cu64)

31

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32886-3

STUDIES WITH RADIOCOPPER (64CU) IN WILSON'S DISEASE: THE LIVER/THIGH RATIO

25 June 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32886-3

25 June 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5742073%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference